460 related articles for article (PubMed ID: 15142632)
21. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
Langer C; Soria JC
Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973
[TBL] [Abstract][Full Text] [Related]
22. Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer.
Khalil MY; Grandis JR; Shin DM
Expert Rev Anticancer Ther; 2003 Jun; 3(3):367-80. PubMed ID: 12820779
[TBL] [Abstract][Full Text] [Related]
23. Potential role for epidermal growth factor receptor inhibitors in combined-modality therapy for non-small-cell lung cancer.
Kim DW; Choy H
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):11-20. PubMed ID: 15142630
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor: a promising target in solid tumours.
Laskin JJ; Sandler AB
Cancer Treat Rev; 2004 Feb; 30(1):1-17. PubMed ID: 14766123
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis inhibitors: a rational strategy for radiosensitization in the treatment of non-small-cell lung cancer?
Raben D; Helfrich B
Clin Lung Cancer; 2004 Jul; 6(1):48-57. PubMed ID: 15310417
[TBL] [Abstract][Full Text] [Related]
26. Combination epidermal growth factor receptor inhibition and radical radiotherapy for NSCLC.
Rogers SJ; Harrington KJ; Eccles SA; Nutting CM
Expert Rev Anticancer Ther; 2004 Aug; 4(4):569-83. PubMed ID: 15270661
[TBL] [Abstract][Full Text] [Related]
27. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.
Lage A; Crombet T; González G
Ann Med; 2003; 35(5):327-36. PubMed ID: 12952019
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.
Ang KK; Andratschke NH; Milas L
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):959-65. PubMed ID: 14967456
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor as a target to improve treatment of lung cancer.
Andratschke NH; Dittmann KH; Mason KA; Fan Z; Liao Z; Komaki R; Ang KK; Milas L
Clin Lung Cancer; 2004 May; 5(6):340-52. PubMed ID: 15217533
[TBL] [Abstract][Full Text] [Related]
30. Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors.
Ochs JS
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):941-9. PubMed ID: 14967454
[TBL] [Abstract][Full Text] [Related]
31. EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.
Xu Y; Zhang Y; Ma S
Lung Cancer; 2011 Sep; 73(3):249-55. PubMed ID: 21641672
[TBL] [Abstract][Full Text] [Related]
32. Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy.
Koh PK; Faivre-Finn C; Blackhall FH; De Ruysscher D
Cancer Treat Rev; 2012 Oct; 38(6):626-40. PubMed ID: 22196919
[TBL] [Abstract][Full Text] [Related]
33. Novel therapies in non-small cell lung cancer.
Zaba O; Grohe C; Merk J
Minerva Chir; 2011 Jun; 66(3):235-44. PubMed ID: 21666560
[TBL] [Abstract][Full Text] [Related]
34. Novel targeted therapies for non-small cell lung cancer.
Smith PW; Denlinger CE; Jones DR
Thorac Surg Clin; 2006 Nov; 16(4):353-66. PubMed ID: 17240823
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
Raben D; Bianco C; Milas L; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):139-52. PubMed ID: 15095260
[TBL] [Abstract][Full Text] [Related]
36. Targeting epidermal growth factor receptor in head and neck cancer.
Ford AC; Grandis JR
Head Neck; 2003 Jan; 25(1):67-73. PubMed ID: 12478546
[TBL] [Abstract][Full Text] [Related]
37. Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy.
Morgillo F; Bareschino MA; Bianco R; Tortora G; Ciardiello F
Differentiation; 2007 Nov; 75(9):788-99. PubMed ID: 17608727
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer.
Bunn PA; Franklin W
Semin Oncol; 2002 Oct; 29(5 Suppl 14):38-44. PubMed ID: 12422312
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor inhibitors in clinical development.
Dancey J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):1003-7. PubMed ID: 14967462
[TBL] [Abstract][Full Text] [Related]
40. Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancer.
Reck M; Crinò L
Lung Cancer; 2009 Jan; 63(1):1-9. PubMed ID: 18579254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
